Page 52 - Eceptor News Today

Researchers developed a novel intranasal vaccine candidate for coronavirus disease 2019 (COVID-19).

Researchers perform extensive multiscale investigations to explore virological characteristics of the SARS-CoV-2 Omicron XBB subvariant, XBB.1.16.

A new tool that can uncover the developmental history of certain immune cells is now freely available worldwide. The tool provides insights into the stages that immune cells go through in a healthy individual and how this can be impacted in disease.

MyJournals.org - Science - IJMS, Vol. 24, Pages 7177: Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis (International Journal of Molecular Sciences)

Despite the success of vaccines for preventing COVID-19, and of drugs for treating the disease, outcomes for severely ill patients admitted to the hospital remains poor.

Reported the identification of a panel of vaccinee-derived antibodies with broad-spectrum neutralization activity.

Researchers found antibodies that neutralize all current SARS-CoV-2 variants.

A study investigating risk factors and vectors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) household transmission reveals that the presence of the virus on the hands of primary and secondary cases and on frequently-touched surfaces is associated with transmission risk. The study is published in the journal THE LANCET Microbe.

Researchers highlight how dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.

Scientists at UC San Francisco (UCSF) have created the first molecular-level, 3D picture of how an odour molecule activates a human odorant receptor, breaking a long-standing impasse in our understanding of olfaction.